Checkpoint Inhibitors in Cancer Treatment

This chapter explores the mechanisms of action of checkpoint inhibitors in activating the immune system against cancer cells, highlighting the potential risks of autoimmune reactions and the importance of managing immune-related adverse events during therapy.